| For: | Löhn M, Plettenburg O, Kannt A, Kohlmann M, Hofmeister A, Kadereit D, Monecke P, Schiffer A, Schulte A, Ruetten H, Ivashchenko Y. End-organ protection in hypertension by the novel and selective Rho-kinase inhibitor, SAR407899. World J Cardiol 2015; 7(1): 31-42 [PMID: 25632317 DOI: 10.4330/wjc.v7.i1.31] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v7/i1/31.htm |
| Number | Citing Articles |
| 1 |
William H. Nugent, Nikita Mishra, Jerome F. Strauss, Scott W. Walsh. Matrix Metalloproteinase 1 Causes Vasoconstriction and Enhances Vessel Reactivity to Angiotensin II via Protease-Activated Receptor 1. Reproductive Sciences 2016; 23(4) doi: 10.1177/1933719115607998
|
| 2 |
Tilahun Ayane Debele, Zachary F. Mount, Yong Yuan, Winston W.-Y. Kao, Yoonjee C. Park. The Effects of ROCK Inhibitor on Prevention of Dexamethasone-Induced Glaucoma Phenotype in Human Trabecular Meshwork Cells. Translational Vision Science & Technology 2023; 12(12) doi: 10.1167/tvst.12.12.4
|
| 3 |
Alan R. Parrish. The cytoskeleton as a novel target for treatment of renal fibrosis. Pharmacology & Therapeutics 2016; 166 doi: 10.1016/j.pharmthera.2016.06.006
|
| 4 |
Ghadeer Al-Humimat, Ibtisam Marashdeh, Duaa Daradkeh, Karanjit Kooner. Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma. Journal of Experimental Pharmacology 2021; doi: 10.2147/JEP.S259297
|
| 5 |
Yuto Yasuda, Lu Wang, Pasquale Chitano, Chun Y. Seow. Rho-Kinase Inhibition of Active Force and Passive Tension in Airway Smooth Muscle: A Strategy for Treating Airway Hyperresponsiveness in Asthma. Biology 2024; 13(2) doi: 10.3390/biology13020115
|
| 6 |
R Jay Widmer, Lilach O Lerman, Amir Lerman. The Rho(ad)-kinase for individualized treatment of vasospastic angina. European Heart Journal 2018; 39(11) doi: 10.1093/eurheartj/ehx757
|
| 7 |
David Mondaca-Ruff, Patricio Araos, Cristián E. Yañez, Ulises F. Novoa, Italo G. Mora, María Paz Ocaranza, Jorge E. Jalil. Hydrochlorothiazide Reduces Cardiac Hypertrophy, Fibrosis and Rho-Kinase Activation in DOCA-Salt Induced Hypertension. Journal of Cardiovascular Pharmacology and Therapeutics 2021; 26(6) doi: 10.1177/10742484211053109
|
| 8 |
Yangbo Feng, Philip V. LoGrasso, Olivier Defert, Rongshi Li. Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential. Journal of Medicinal Chemistry 2016; 59(6) doi: 10.1021/acs.jmedchem.5b00683
|
| 9 |
Chunying Luo, Maxwell Ampomah-Wireko, Huanhuan Wang, Chunli Wu, Qing Wang, Hui Zhang, Yaquan Cao. Isoquinolines: Important Cores in Many Marketed and Clinical Drugs. Anti-Cancer Agents in Medicinal Chemistry 2021; 21(7) doi: 10.2174/1871520620666200424132248
|
| 10 |
Maria P. Ocaranza, Camila Fierro, Jorge E. Jalil, Jackeline Moya, Leticia Gonzalez, Cristián Molina, Cristián Mancilla. Rho kinase activation in circulating leukocytes is related to hypertensive myocardial remodeling. Clinical Science 2018; 132(16) doi: 10.1042/CS20180312
|